
Tarsons Products Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-06-12 08:05:06Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, signalling increased bearishness. The stock’s recent price action, combined with mixed technical indicator readings, paints a challenging picture for investors amid a broader market context that has seen the company underperform the Sensex over multiple time frames.
Read full news article
Tarsons Products Ltd is Rated Strong Sell
2026-06-03 10:11:05Tarsons Products Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Tarsons Products Ltd Downgraded to Strong Sell Amid Deteriorating Quality Metrics
2026-05-26 08:00:26Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has seen its quality grade downgraded from average to below average as of 25 May 2026. This shift reflects deteriorating business fundamentals, including weakening profitability metrics, stretched debt levels, and inconsistent growth patterns, which have raised concerns among investors and analysts alike.
Read full news articleAre Tarsons Products Ltd latest results good or bad?
2026-05-23 19:25:56Tarsons Products Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by significant revenue growth juxtaposed with sharp declines in profitability. The company achieved its highest-ever quarterly revenue of ₹120.93 crores, marking a sequential growth of 12.09% compared to the previous quarter. However, this revenue achievement was overshadowed by a notable contraction in net profit, which fell to ₹4.18 crores, reflecting a year-on-year decline of 59.02%. The operating margin also experienced a decline, dropping to 28.34% from 32.85% in the same quarter of the previous year, indicating mounting operational pressures. This margin compression is attributed to rising employee costs, which increased by 21.19% year-on-year, and a significant rise in depreciation expenses, which surged by 45.18%. Additionally, interest costs rose by 20.19%, further straining profitabil...
Read full news article
Tarsons Products Ltd is Rated Sell
2026-05-23 10:10:47Tarsons Products Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Tarsons Products Q4 FY26: Margin Compression and Profit Decline Signal Operational Headwinds
2026-05-22 22:32:22Tarsons Products Ltd., a micro-cap healthcare services company with a market capitalisation of ₹1,125 crores, reported a challenging fourth quarter for FY26, with net profit declining 59.02% year-on-year to ₹4.18 crores despite revenue growth of 7.31%. The stock, trading at ₹218.25 as of May 22, 2026, has witnessed significant volatility, down 42.87% over the past year, substantially underperforming both the benchmark Sensex and its healthcare services sector peers.
Read full news articleWhen is the next results date for Tarsons Products Ltd?
2026-05-19 23:19:07The next results date for Tarsons Products Ltd is scheduled for 22 May 2026....
Read full news article
Tarsons Products Ltd is Rated Sell
2026-05-12 10:11:08Tarsons Products Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 May 2026, providing investors with an up-to-date view of its performance and outlook.
Read full news article
Tarsons Products Ltd is Rated Sell
2026-05-01 10:10:42Tarsons Products Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Jun-2026 | Source : BSEIntimation of Schedule of Analyst/Institutional Investor Meeting(s)
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Jun-2026 | Source : BSEIntimation of Schedule of Analyst/Institutional Investor Meeting(s)
Intimation Under Regulation 30 Of SEBI LODR Regulations 2015 Regarding Equity Investment.
03-Jun-2026 | Source : BSEIntimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Corporate Actions
No Upcoming Board Meetings
Tarsons Products Ltd has declared 100% dividend, ex-date: 20 Sep 24
No Splits history available
No Bonus history available
No Rights history available






